Picture of Palvella Therapeutics logo

PVLA — Palvella Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Pieris Pharmaceuticals Inc - Net Loss Was $5.1 Million Or $0.07 Per Share For The Quarter Ended March 31, 2022

May 11 (Reuters) - Pieris Pharmaceuticals Inc  PIRS.O :
    * PIERIS PHARMACEUTICALS INC - NET LOSS WAS $5.1 MILLION OR
$0.07
PER SHARE FOR THE QUARTER ENDED MARCH 31, 2022
    * PIERIS PHARMACEUTICALS INC -  BELIEVES REPORTED CASH IS
SUFFICIENT TO FUND OPERATIONS INTO THE FOURTH QUARTER OF 2023

Further company coverage:  PIRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Palvella Therapeutics

See all news